Ecdysterone
Best-in-class: Ecdysterone
A plant ecdysteroid (from spinach/quinoa) studied for muscle growth without hormonal side effects — the one with an actual (if debated) human study.
Ecdysterone quick facts
| Suggested dose | Often several hundred mg standardized daily (based on the study). |
| How often | Daily |
| Who it's for | Lifters seeking natural muscle support. |
That single trial is doing an enormous amount of work in the marketing, and it has not been independently replicated. Product analyses have repeatedly found actual ecdysterone content far below label. Interesting mechanism, thin evidence, poor quality control across the category — a fair summary is that it deserves a proper trial rather than the confidence currently attached to it.
How Ecdysterone actually works
20-hydroxyecdysone is an insect moulting hormone. The proposed human mechanism is binding the estrogen receptor beta subtype, which triggers protein synthesis through a non-androgenic route — meaning no androgen receptor involvement and therefore no suppression of the HPG axis. One German trial in resistance-trained men reported hypertrophy substantial enough that WADA added it to the monitoring list.
Where to get Ecdysterone
Find Ecdysterone on iHerb →The evidence for Ecdysterone
Graded by what exists behind each claim.
✅ Clinically validated
- A German study reported meaningful lean-mass/strength gains over 10 weeks; other data is animal/mechanistic.
- Acts via estrogen-receptor-beta, not androgen receptors (no steroid side effects).
📊 Correlative data
- Present in spinach and quinoa, and the compound has decades of reported use in Soviet and Eastern Bloc sports programs — real exposure, no recoverable methodology. WADA has considered it for the monitoring program, which is itself a statement about perceived effect.
🧪 Theoretical / extrapolated benefits
- More human evidence than turkesterone, but product purity/dosing is a major real-world issue.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Ecdysterone actually does
20-hydroxyecdysone is an insect molting hormone, and the first thing to say about it is that mammals have no ecdysone receptor. In arthropods it acts through a nuclear receptor heterodimer, EcR with Ultraspiracle, which does not exist in humans. So every proposed human mechanism has to be an off-target one, and the candidates have been catalogued: estrogen receptor beta, the Mas1 receptor, and downstream PI3K/Akt signaling Zádor 2025.
The estrogen-receptor-beta route is the one the anabolic claim rests on, and it has recently been examined at molecular level. Ecdysterone is proposed to bind ER-beta, which is expressed in skeletal muscle, and to drive protein synthesis through Akt and mTOR without touching the androgen receptor — the reason it is marketed as anabolic without androgenic side effects Tariq 2025. The claim is coherent and it is not the same thing as demonstrated: ER-beta activation in muscle is a hypothesis being tested, not an established pathway with a dose-response in people.
A second candidate target sends the pharmacology somewhere else. The review of 20-hydroxyecdysone's route from plant extract to clinical use identifies Mas1 receptor activation as the main mechanism behind its documented anabolic, lipid-lowering, anti-inflammatory and hepatoprotective effects Dinan 2021. Mas1 is the receptor for angiotensin-(1–7). If that is the real target, this compound is a cardiometabolic agent that happens to affect muscle, and the two mechanistic stories in the literature have not been reconciled with each other Zádor 2025.
The pharmacokinetics are the part that decides whether any of this can happen at a supplement dose, and they have been measured properly. A Phase 1 study of BIO101, purified 20-hydroxyecdysone at 97% or better, gave single ascending doses of 100 to 1400 mg to 16 young adults and 1400 mg to 8 adults aged 65 or over, then 14 days of 350 mg once daily, 350 mg twice daily or 450 mg twice daily to 10 older adults Dioh 2023.
Two numbers from that study govern everything. Mean half-life was 2.4 to 4.9 hours, and mean Cmax and area under the curve increased less than dose-proportionally from 100 mg to 1400 mg Dioh 2023. A half-life of a few hours means a once-daily capsule leaves the compound effectively absent for most of the day. Less-than-proportional exposure means absorption saturates, so doubling the capsules does not double what reaches the muscle. Renal clearance was 4.05 to 5.05 L/h across doses and accumulation over 14 days was modest, with a mean accumulation ratio of 1.31 on twice-daily dosing Dioh 2023. Two major metabolites were identified and quantified: 14-deoxy-20-hydroxyecdysone and 14-deoxypoststerone.
Cell, rodent, human — and where it stops
The most useful human study in this category is the one that assayed its own supplement, and what it found is the page. Twenty-eight resistance-trained young men were randomized to a commercially available 20-hydroxyecdysone and diosgenin product, taken three times a day as the label directed, or to placebo, alongside free-weight resistance training three times a week for 12 weeks, with assessments at baseline, 4, 8 and 12 weeks Dissemond 2025.
The training worked and the supplement did nothing. One-repetition maximum for squat and bench press improved significantly in both groups — a time effect with no group effect — and the same pattern held for fat-free mass, muscle mass, fat mass and muscle thickness at the pectoralis major and at the anterior and lateral quadriceps Dissemond 2025. Twenty-four men completed.
Then they analyzed the capsules, and this is the finding worth remembering. Liquid chromatography with tandem mass spectrometry measured less than 1% of the claimed 20-hydroxyecdysone concentration and 10.4% of the claimed diosgenin, and the product produced no biological activity and no hypertrophic effect in C2C12 muscle cells Dissemond 2025. The trial did not test ecdysterone. It tested a capsule that did not contain any meaningful amount of it.
That single result reorganizes how every other ecdysterone study should be read. The authors' own recommendations are that future work must verify active compound concentration in the supplement, confirm the absence of contamination with prohibited substances, and confirm biological activity in an in vitro model before dosing anyone Dissemond 2025. Any trial that skipped those steps may have been measuring an empty capsule, in either direction.
The clean pharmacology chain, by contrast, is short and it does not reach muscle. Purified 20-hydroxyecdysone has been through toxicology in rat and dog and a Phase 1 in humans, which established safety and pharmacokinetics and selected doses for later trials in age-related sarcopenia Dioh 2023. The Phase 1 measured myostatin, procollagen-III-amino-terminal propeptide, myoglobin, creatine kinase MB, renin and aldosterone; reductions in mean myoglobin and creatine kinase MB from baseline were seen at 450 mg twice daily Dioh 2023. Those are pharmacodynamic signals in a dose-finding study, not a strength result.
The obstacle, stated plainly. The compound with real human pharmacokinetics is a purified investigational drug at 97% or better Dioh 2023, dosed at 350 to 900 mg a day in divided doses. The material on the shelf is a plant extract whose one published assay returned under 1% of label Dissemond 2025. Those are not the same product and no result transfers between them.
Ecdysterone — which form, and does it matter
Purity is not a quality tier here. It is the difference between two different substances. The Phase 1 compound is specified as 20E at greater than or equal to 97% Dioh 2023. The commercial product that was assayed contained under 1% of its claimed 20E Dissemond 2025. Between those two lies every product on the market, and nothing on a label distinguishes them.
The plant-source claim deserves arithmetic rather than romance. 20-hydroxyecdysone occurs in spinach and quinoa at low concentrations, which is why the route to usable quantities has been the development of dedicated manufacturing processes for pharmaceutical-grade material rather than extraction from salad Dinan 2021. A product advertising a high 20E dose “from spinach” is describing a botanical origin, not a concentration, and the two are being conflated deliberately.
Ecdysterone and turkesterone are different molecules and the evidence does not cross between them. Turkesterone carries an extra hydroxyl and has no human pharmacokinetic study, no purified clinical candidate and no assay-verified trial. Everything on this page is about 20-hydroxyecdysone Dioh 2023 Dinan 2021 and none of it should be read across.
Dosing schedule is part of the form, and the half-life settles it. At 2.4 to 4.9 hours Dioh 2023, a once-daily capsule produces a spike and then several hours of nothing. The Phase 1 multiple-dose arms used twice-daily administration for that reason, and accumulated only modestly. A product directing once-daily use is not delivering the exposure pattern the human pharmacokinetic study was built around.
The single question worth asking a seller. Ask for a third-party certificate of analysis stating measured 20-hydroxyecdysone by liquid chromatography with mass spectrometry, with the lot number on it. That is exactly the verification step the one assay-carrying trial recommends Dissemond 2025, and refusing it is an answer.
What would have to be true, and how you would know it was not
1. The prediction that separates the compound from the capsule. Predict that a product with no lot-level assay produces no measurable change in fat-free mass, muscle thickness or one-repetition maximum beyond what training alone produces over 12 weeks — because that is precisely what happened when a labeled product was tested and then measured Dissemond 2025. Markers: DXA or bioimpedance fat-free mass, ultrasound muscle thickness, 1-RM. Retest window: 12 weeks, with a matched non-supplemented training block as the comparison.
2. Predict the urinary check disagrees with the label. Ecdysterone and its two identified metabolites, 14-deoxy-20-hydroxyecdysone and 14-deoxypoststerone, are measurable Dioh 2023. Predict that in someone taking a supplement claiming several hundred milligrams a day, urinary ecdysterone is far lower than the same dose of purified material would produce. This is the cheapest available test of whether a capsule contains what it says.
3. Predict no androgenic signature, and treat any as a red flag. Predict total and free testosterone, LH, FSH and SHBG unchanged, and hematocrit unchanged, because the proposed targets are ER-beta and Mas1 rather than the androgen receptor Tariq 2025 Dinan 2021. Retest window: 8 to 12 weeks. Suppressed LH or a rising hematocrit on an ecdysterone product means something androgenic is present that the label does not declare — which is the contamination the assay-carrying trial explicitly warns future researchers to screen for Dissemond 2025.
4. Predict exposure does not scale with capsule count. Cmax and area under the curve rose less than dose-proportionally from 100 to 1400 mg Dioh 2023. So predict that doubling a dose produces less than double the plasma concentration, and that the strategy of taking more to compensate for a weak product fails on absorption before it fails on cost.
What nobody has tested yet
Nobody has run a resistance-training trial on assay-verified material. That is the whole gap. Purified 20E has human pharmacokinetics Dioh 2023; a commercial product has a null training result and an assay showing it was empty Dissemond 2025. The study that has never been done is 12 weeks of training with 350 to 450 mg twice daily of material certified at 97% purity, which is a trial somebody could start tomorrow.
Nobody has settled which receptor matters. ER-beta Tariq 2025 and Mas1 Dinan 2021 are both proposed as the principal target and the molecular-targets review treats the question as open Zádor 2025. A receptor-knockout or antagonist-blockade experiment in a muscle model would decide it and has not been reported.
Nobody has measured what the metabolites do. Two major human metabolites were identified and quantified in the Phase 1 study Dioh 2023 and neither has been tested for activity at either candidate receptor. If one of them is the active species, the entire dosing literature is aimed at the wrong molecule.
And nobody has published a market survey. One product has been assayed and reported Dissemond 2025. Whether it is representative or an outlier is unknown, and buying thirty products and running them would be a week of work and the most useful paper anyone could write about this category.
Ecdysterone — its own safety story, not its category's
The best safety data belongs to a drug candidate, not to a supplement, and that distinction cuts both ways. Purified 20-hydroxyecdysone showed a good safety profile with only mild to moderate adverse events across single doses from 100 to 1400 mg and 14 days of dosing up to 450 mg twice daily, in young and older adults Dioh 2023. That is reassuring about the molecule and says nothing about a capsule whose contents were not verified Dissemond 2025.
The specific hazard on this page is what fills the gap when the declared active is absent. A product measured at under 1% of its claimed 20E Dissemond 2025 contains something, and the same paper recommends that future studies confirm the absence of contamination with prohibited substances. For anyone drug-tested, that is not an abstract concern: an undeclared androgen in a product bought for its non-androgenic mechanism is the worst version of this problem.
Blood work was checked and it was unremarkable. The 12-week training trial measured liver and kidney function and endocrine parameters before and after Dissemond 2025, and the Phase 1 study followed safety across ascending doses Dioh 2023. There is no signal to report. There is also, by the trial's own assay, very little 20E to have caused one.
Duration is the honest unknown. The human exposure data runs to 14 days at pharmaceutical purity Dioh 2023 and 12 weeks at unverified content Dissemond 2025. Nothing supports a statement about taking this daily for years, and the anti-aging framing that has grown up around the molecule Zádor 2025 is a hypothesis about a timescale nobody has studied.
Who should not take it. Anyone subject to anti-doping testing, on the contamination argument above; anyone with a hormone-sensitive condition, since the leading proposed mechanism is an estrogen receptor Tariq 2025; and anyone in pregnancy or breastfeeding, where a compound with an unresolved receptor target and an unverified label has nothing in its favor.
Sources read for this page
- Dissemond J. How reliable is the labeling of a commercial phytosteroid product? A 12-week randomized double-blind training study. J Int Soc Sports Nutr 2025 · PMID 40781783
- Dioh W. A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults. J Cachexia Sarcopenia Muscle 2023 · PMID 37057316
- Dinan L. 20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases. Biomedicines 2021 · PMID 33947076
- Tariq SS. Molecular insights into the role of Estrogen Receptor Beta in Ecdysterone Mediated Anabolic Activity. PLoS One 2025 · PMID 40455734
- Zádor E. Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound?. Cells 2025 · PMID 40136680
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Lean mass and strength across a fixed block, measured the same way every time: the same lifts at the same loads, the same scale at the same hour, and body composition by the same method if you have access to one. The study everyone quotes reported gains across ten weeks alongside resistance training, so a ten-week block with your training held constant is the honest replication of it.
- How long before it means anything: Ten weeks minimum, with the program and the calories fixed throughout. Change either one part-way and the experiment is over even if the numbers move.
- What will fool you: The product, before anything else. Independent analyses of ecdysteroid supplements have repeatedly found far less than the label claims or none of it at all, so buy something third-party tested or accept that a null result tells you about the tub rather than the compound. Then the evidence itself: this rests on one study, which is what makes it the best of a thin category rather than a settled result. If you are drug tested, note it has been considered for the WADA monitoring program — the rules can move under you.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Ecdysterone — safety & side effects
- Well tolerated in the limited human data; no consistent side effects reported.
- Not a hormone and does not suppress testosterone — the most common misconception. It is also on WADA's monitoring list, which matters if you are tested.
- Label accuracy is the real problem: independent testing has found most products contain a fraction of the claimed dose or none at all.
The same on every page it applies to. Read it here; it is not repeated research.
- Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Ecdysterone in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Ecdysterone
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Hemoglobin sets your ceiling for endurance work |
| Ferritin | Low iron limits performance long before anemia shows |
| Total Testosterone | Drops under genuine overreaching |
| Comprehensive Metabolic Panel (CMP) | Kidney and electrolytes under heavy training load |
The Athletic Performance & Recovery panel covers these in one order — 12 markers, $207.90 with the discount applied.
Check results you already have → · All 103 markers A–Z
Ecdysterone — frequently asked questions
What is Ecdysterone?
A plant ecdysteroid (from spinach/quinoa) studied for muscle growth without hormonal side effects — the one with an actual (if debated) human study.
What is the suggested dose of Ecdysterone?
Often several hundred mg standardized daily (based on the study). This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Ecdysterone dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Ecdysterone?
Coach Cam sources Ecdysterone from vetted, top-rated brands on iHerb — use the buy link on this page.
What Ecdysterone is used for
Ecdysterone appears under 1 goal in the goal router.
Related Performance supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.